{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34257817", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "05"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "23"}], "Language": ["eng"], "ELocationID": ["6678662", "10.1155/2021/6678662"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence.", "Pagination": {"StartPage": "6678662", "MedlinePgn": "6678662"}, "Abstract": {"AbstractText": ["Metabolic diseases have become major public health issues worldwide. Searching for effective drugs for treating metabolic diseases from natural compounds has attracted increasing attention. Quercetin, an important natural flavonoid, is extensively present in fruits, vegetables, and medicinal plants. Due to its potentially beneficial effects on human health, quercetin has become the focus of medicinal attention. In this review, we provide a timely and comprehensive summary of the pharmacological advances and clinical data of quercetin in the treatment of three metabolic diseases, including diabetes, hyperlipidemia, and nonalcoholic fatty liver disease (NAFLD). Accumulating evidences obtained from animal experiments prove that quercetin has beneficial effects on these three diseases. It can promote insulin secretion, improve insulin resistance, lower blood lipid levels, inhibit inflammation and oxidative stress, alleviate hepatic lipid accumulation, and regulate gut microbiota disorders in animal models. However, human clinical studies on the effects of quercetin in diabetes, hyperlipidemia, and NAFLD remain scarce. More clinical trials with larger sample sizes and longer trial durations are needed to verify its true effectiveness in human subjects. Moreover, another important issue that needs to be resolved in future research is to improve the bioavailability of quercetin. This review may provide valuable information for the basic research, drug development, and clinical application of quercetin in the treatment of metabolic diseases."], "CopyrightInformation": "Copyright \u00a9 2021 Huan Yi et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China."}], "LastName": "Yi", "ForeName": "Huan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Animal Health Research Institute, Tongwei Co., Ltd., Chengdu 610041, China."}], "LastName": "Peng", "ForeName": "Hengyang", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China."}], "LastName": "Wu", "ForeName": "Xinyue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China."}], "LastName": "Xu", "ForeName": "Xinmei", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China."}], "LastName": "Kuang", "ForeName": "Tingting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China."}], "LastName": "Zhang", "ForeName": "Jing", "Initials": "J"}, {"Identifier": ["0000-0002-3597-3596"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China."}], "LastName": "Du", "ForeName": "Leilei", "Initials": "L"}, {"Identifier": ["0000-0002-3023-9472"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China."}, {"Identifier": [], "Affiliation": "School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China."}], "LastName": "Fan", "ForeName": "Gang", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Metabolic Diseases"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Quercetin"}, {"QualifierName": [], "DescriptorName": "Young Adult"}], "CoiStatement": "The authors declare that there is no conflict of interest regarding the publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Costello K. R., Schones D. E. Chromatin modifications in metabolic disease: potential mediators of long-term disease risk. Wiley Interdisciplinary Reviews: Systems Biology and Medicine. 2018;10(4, article e1416) doi: 10.1002/wsbm.1416.", "ArticleIdList": ["10.1002/wsbm.1416", "PMC6002879", "29369528"]}, {"Citation": "Saeedi P., Petersohn I., Salpea P., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Research and Clinical Practice. 2019;157 doi: 10.1016/j.diabres.2019.107843.", "ArticleIdList": ["10.1016/j.diabres.2019.107843", "31518657"]}, {"Citation": "Group DPPR. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. The Lancet. 2009;374:1677\u20131686. doi: 10.1016/s0140-6736(09)61457-4.", "ArticleIdList": ["10.1016/s0140-6736(09)61457-4", "PMC3135022", "19878986"]}, {"Citation": "Liu L. K., Chou F. P., Chen Y. C., Chyau C. C., Ho H. H., Wang C. J. Effects of mulberry (Morus alba L.) extracts on lipid homeostasis in vitro and in vivo. Journal of Agricultural and Food Chemistry. 2009;57(16):7605\u20137611. doi: 10.1021/jf9014697.", "ArticleIdList": ["10.1021/jf9014697", "19630385"]}, {"Citation": "Scott R. S., Lintott C. J., Wilson M. J. Simvastatin and side effects. The New Zealand Medical Journal. 1991;104(924):493\u2013495.", "ArticleIdList": ["1745460"]}, {"Citation": "Kanwar P., Kowdley K. V. The metabolic syndrome and its influence on nonalcoholic steatohepatitis. Clinics in Liver Disease. 2016;20(2):225\u2013243. doi: 10.1016/j.cld.2015.10.002.", "ArticleIdList": ["10.1016/j.cld.2015.10.002", "27063266"]}, {"Citation": "Ali R., Cusi K. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD) Annals of Medicine. 2009;41(4):265\u2013278. doi: 10.1080/07853890802552437.", "ArticleIdList": ["10.1080/07853890802552437", "19353360"]}, {"Citation": "Bacanli M., Dilsiz S. A., Basaran N., Basaran A. A. Effects of phytochemicals against diabetes. Advances in Food and Nutrition Research. 2019;89:209\u2013238. doi: 10.1016/bs.afnr.2019.02.006.", "ArticleIdList": ["10.1016/bs.afnr.2019.02.006", "31351526"]}, {"Citation": "Sahebkar A. Effects of quercetin supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition. 2017;57(4):666\u2013676. doi: 10.1080/10408398.2014.948609.", "ArticleIdList": ["10.1080/10408398.2014.948609", "25897620"]}, {"Citation": "Maalik A., Khan F. A., Mumtaz A., et al. Pharmacological applications of quercetin and its derivatives: a short review. Tropical Journal of Pharmaceutical Research. 2014;13(9):1561\u20131566. doi: 10.4314/tjpr.v13i9.26.", "ArticleIdList": ["10.4314/tjpr.v13i9.26"]}, {"Citation": "Zhang X.-W., Chen J.-Y., Ouyang D., Lu J.-H. Quercetin in animal models of Alzheimer\u2019s disease: a systematic review of preclinical studies. International Journal of Molecular Sciences. 2020;21(2):p. 493. doi: 10.3390/ijms21020493.", "ArticleIdList": ["10.3390/ijms21020493", "PMC7014205", "31941000"]}, {"Citation": "Zhang W., Wang Y., Yang Z., et al. Antioxidant treatment with quercetin ameliorates erectile dysfunction in streptozotocin-induced diabetic rats. Journal of Bioscience and Bioengineering. 2011;112(3):215\u2013218. doi: 10.1016/j.jbiosc.2011.05.013.", "ArticleIdList": ["10.1016/j.jbiosc.2011.05.013", "21664865"]}, {"Citation": "Yao Z., Gu Y., Zhang Q., et al. Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults. European Journal of Nutrition. 2019;58(2):819\u2013830. doi: 10.1007/s00394-018-1713-2.", "ArticleIdList": ["10.1007/s00394-018-1713-2", "29754250"]}, {"Citation": "Talirevic E., Sehovic J. Quercetin in the treatment of dyslipidemia. Medicinski Arhiv. 2012;66(2):87\u201388. doi: 10.5455/medarh.2012.66.87-88.", "ArticleIdList": ["10.5455/medarh.2012.66.87-88", "22486135"]}, {"Citation": "Prysyazhnyuk V., Voloshyn O. Effects of comprehensive treatment with quercetin administration on biochemical blood parameters and pro-and anti-inflammatory cytokines in nonalcoholic fatty liver disease patients. The Pharma Innovation Journal. 2017;6:386\u2013389."}, {"Citation": "Xiao L., Luo G., Tang Y., Yao P. Quercetin and iron metabolism: what we know and what we need to know. Food and Chemical Toxicology. 2018;114:190\u2013203. doi: 10.1016/j.fct.2018.02.022.", "ArticleIdList": ["10.1016/j.fct.2018.02.022", "29432835"]}, {"Citation": "Nishimuro H., Ohnishi H., Sato M., et al. Estimated daily intake and seasonal food sources of quercetin in Japan. Nutrients. 2015;7(4):2345\u20132358. doi: 10.3390/nu7042345.", "ArticleIdList": ["10.3390/nu7042345", "PMC4425148", "25849945"]}, {"Citation": "Somerset S. M., Johannot L. Dietary flavonoid sources in Australian adults. Nutrition and Cancer. 2008;60(4):442\u2013449. doi: 10.1080/01635580802143836.", "ArticleIdList": ["10.1080/01635580802143836", "18584477"]}, {"Citation": "Hakkinen S. H., Karenlampi S. O., Heinonen I. M., Mykkanen H. M., Torronen A. R. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. Journal of Agricultural and Food Chemistry. 1999;47(6):2274\u20132279. doi: 10.1021/jf9811065.", "ArticleIdList": ["10.1021/jf9811065", "10794622"]}, {"Citation": "Verma N., Trehan N. HPLC analysis of methanolic extract of herbs for quercetin content. Journal of Pharmacognosy and Phytochemistry. 2013;2:159\u2013162."}, {"Citation": "Patil B. S., Pike L. M., Yoo K. S. Variation in the quercetin content in different colored onions (Allium cepa L.) Journal of the American Society for Horticultural Science. 1995;120(6):909\u2013913. doi: 10.21273/JASHS.120.6.909.", "ArticleIdList": ["10.21273/JASHS.120.6.909"]}, {"Citation": "Ulusoy H. G., Sanlier N. A minireview of quercetin: from its metabolism to possible mechanisms of its biological activities. Critical Reviews in Food Science and Nutrition. 2020;60(19):3290\u20133303. doi: 10.1080/10408398.2019.1683810.", "ArticleIdList": ["10.1080/10408398.2019.1683810", "31680558"]}, {"Citation": "Mukhopadhyay P., Prajapati A. K. Quercetin in anti-diabetic research and strategies for improved quercetin bioavailability using polymer-based carriers\u2013a review. RSC Advances. 2015;5(118):97547\u201397562. doi: 10.1039/C5RA18896B.", "ArticleIdList": ["10.1039/C5RA18896B"]}, {"Citation": "Yin X. M., Chen L. Y., Zhang X. W. Determination of the quercetin content in the fructus polygoni orientalis. Journal of Medical Science Yanbian University. 2005;4:264\u2013265."}, {"Citation": "Wang D. W., Ma K. F. Content determination of quercetin in Crataegus sanguinea by HPLC. Shizhen Guo Yi Guo Yao. 2008;19:2214\u20132215."}, {"Citation": "Quan Y. C., Guan L. P., Zheng G. H. Study on determination of quercetin in hawthorn leaf by HPLC assay. Shizhen Guo Yi Guo Yao. 2006;17:207\u2013208."}, {"Citation": "Wu S. Q., Chen D. W. Determination and significance of quercetin in Huaimi by HPLC. The Journal of Medical Theory and Practice. 2005;18:730\u2013731."}, {"Citation": "Zhou X., Wang Z. M., Zheng J., Zhao L. W., Liu Z. Y. Determination of quercetin in Chinese herbal medicine by capillary electrophoresis. Chemical Research in Chinese Universities. 2005;26:657\u2013659."}, {"Citation": "Deng Y. D., Yan Z. H., Zhou X. D. Determination of quercetin in guava leaf, Momordica charantiap, Kuding tea by high-performance liquid chromatography. Modern Medicine Journal of China. 2011;13:31\u201332."}, {"Citation": "Yang D. Z., Qi X. P. HPLC for content measurement of quercetin in Polygonum perfoliatum. Asia-Pacific Traditional Medicine. 2011;7:26\u201327."}, {"Citation": "Wei Y., Ding X. J., Bao J. Y. Determination of quercetin in Yuganzi by HPLC. Shizhen Guo Yi Guo Yao. 2008;19:1634\u20131635."}, {"Citation": "Liu M. Y., Xue G. P., Zhang C. S., Shen L. X., Wang J. F. Determination of quercetin in Cuscuta chinensis by HPLC. Shizhen Guo Yi Guo Yao. 2012;23:269\u2013270."}, {"Citation": "Lin X., Liu B. M., Chen M. S. The determination of quercetin in Baeckea frutescens L. by HPLC. Shizhen Guo Yi Guo Yao. 2009;20:102\u2013103."}, {"Citation": "Lv L., Zhu Y. M., Xu D. M. Study on flavones from Taxillus chinensis (DC.) Danser and assay of its quercetin. Chinese Traditional Patent Medicine. 2004;26:1046\u20131048."}, {"Citation": "Ren W. S., Bai T. Y., Chang F. H. Determination of quercetin in Clematis brevicaudata DC by HPLC. Zhongguo Min Zu Yi Yao Za Zhi. 2010;16:50\u201351."}, {"Citation": "Zhou M. M., Ge L. Determination of quercetin content in Dracoephalum mololariea L. by RP-HPLC. Chinese Journal of Ethnomedicine and Ethnopharmacy. 2010;19:1\u20132."}, {"Citation": "Liu H. P., Shi X. F., Zhang Y. C., Li Z. X., Zhang L., Wang Z. Y. Quantitative analysis of quercetin in Euphorbia helioscopia L by RP-HPLC. Cell Biochemistry and Biophysics. 2011;61(1):59\u201364. doi: 10.1007/s12013-011-9161-0.", "ArticleIdList": ["10.1007/s12013-011-9161-0", "21327945"]}, {"Citation": "Mamat T., Ding X. L. RP-HPLC determination of quercetin in Brassica rapa L. for Uighur medicine. Chinese Journal of Pharmaceutical Analysis. 2011;31:1420\u20131422."}, {"Citation": "Heijnen C. G. M., Haenen G. R. M. M., Minou Oostveen R., Stalpers E. M., Bast A. Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited. Free Radical Research Communications. 2002;36(5):575\u2013581. doi: 10.1080/10715760290025951.", "ArticleIdList": ["10.1080/10715760290025951", "12150545"]}, {"Citation": "Wang W., Sun C., Mao L., et al. The biological activities, chemical stability, metabolism and delivery systems of quercetin: a review. Trends in Food Science and Technology. 2016;56:21\u201338. doi: 10.1016/j.tifs.2016.07.004.", "ArticleIdList": ["10.1016/j.tifs.2016.07.004"]}, {"Citation": "Guo Y., Bruno R. S. Endogenous and exogenous mediators of quercetin bioavailability. The Journal of Nutritional Biochemistry. 2015;26(3):201\u2013210. doi: 10.1016/j.jnutbio.2014.10.008.", "ArticleIdList": ["10.1016/j.jnutbio.2014.10.008", "25468612"]}, {"Citation": "Chen X., Yin O. Q., Zuo Z., Chow M. S. Pharmacokinetics and modeling of quercetin and metabolites. Pharmaceutical Research. 2005;22(6):892\u2013901. doi: 10.1007/s11095-005-4584-1.", "ArticleIdList": ["10.1007/s11095-005-4584-1", "15948033"]}, {"Citation": "Li Y., Yao J., Han C., et al. Quercetin, inflammation and immunity. Nutrients. 2016;8(3) doi: 10.3390/nu8030167.", "ArticleIdList": ["10.3390/nu8030167", "PMC4808895", "26999194"]}, {"Citation": "Luca S. V., Macovei I., Bujor A., et al. Bioactivity of dietary polyphenols: the role of metabolites. Critical Reviews in Food Science and Nutrition. 2020;60(4):626\u2013659. doi: 10.1080/10408398.2018.1546669.", "ArticleIdList": ["10.1080/10408398.2018.1546669", "30614249"]}, {"Citation": "Murota K., Terao J. Quercetin appears in the lymph of unanesthetized rats as its phase II metabolites after administered into the stomach. FEBS Letters. 2005;579(24):5343\u20135346. doi: 10.1016/j.febslet.2005.08.060.", "ArticleIdList": ["10.1016/j.febslet.2005.08.060", "16194534"]}, {"Citation": "Erlund I. Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutrition Research. 2004;24(10):851\u2013874. doi: 10.1016/j.nutres.2004.07.005.", "ArticleIdList": ["10.1016/j.nutres.2004.07.005"]}, {"Citation": "Rangel-Ord\u00f3\u00f1ez L., N\u00f6ldner M., Schubert-Zsilavecz M., Wurglics M. Plasma levels and distribution of flavonoids in rat brain after single and repeated doses of standardized Ginkgo biloba extract EGb 761\u00ae. Planta Medica. 2010;76(15):1683\u20131690. doi: 10.1055/s-0030-1249962.", "ArticleIdList": ["10.1055/s-0030-1249962", "20486074"]}, {"Citation": "Bhattacharya S., Oksbjerg N., Young J. F., Jeppesen P. B. Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells. Diabetes, Obesity & Metabolism. 2014;16(7):602\u2013612. doi: 10.1111/dom.12236.", "ArticleIdList": ["10.1111/dom.12236", "24205999"]}, {"Citation": "Carrasco-Pozo C., Tan K. N., Reyes-Farias M., et al. The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic \u03b2-cells, glycemic control and inflammation: In vitro and in vivo studies. Redox Biology. 2016;9:229\u2013243. doi: 10.1016/j.redox.2016.08.007.", "ArticleIdList": ["10.1016/j.redox.2016.08.007", "PMC5011185", "27591402"]}, {"Citation": "Suganya N., Dornadula S., Chatterjee S., Mohanram R. K. Quercetin improves endothelial function in diabetic rats through inhibition of endoplasmic reticulum stress-mediated oxidative stress. European Journal of Pharmacology. 2018;819:80\u201388. doi: 10.1016/j.ejphar.2017.11.034.", "ArticleIdList": ["10.1016/j.ejphar.2017.11.034", "29169872"]}, {"Citation": "Youl E., Bardy G., Magous R., et al. Quercetin potentiates insulin secretion and protects INS-1 pancreatic \u03b2-cells against oxidative damage via the ERK1/2 pathway. British Journal of Pharmacology. 2010;161(4):799\u2013814. doi: 10.1111/j.1476-5381.2010.00910.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00910.x", "PMC2992896", "20860660"]}, {"Citation": "Bardy G., Virsolvy A., Quignard J. F., et al. Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. British Journal of Pharmacology. 2013;169(5):1102\u20131113. doi: 10.1111/bph.12194.", "ArticleIdList": ["10.1111/bph.12194", "PMC3696332", "23530660"]}, {"Citation": "Zhuang M., Qiu H., Li P., Hu L., Wang Y., Rao L. Islet protection and amelioration of type 2 diabetes mellitus by treatment with quercetin from the flowers of Edgeworthia gardneri. Drug Design, Development and Therapy. 2018;12:955\u2013966. doi: 10.2147/DDDT.S153898.", "ArticleIdList": ["10.2147/DDDT.S153898", "PMC5918626", "29720871"]}, {"Citation": "Kittl M., Beyreis M., Tumurkhuu M., et al. Quercetin stimulates insulin secretion and reduces the viability of rat INS-1 beta-cells. Cellular Physiology and Biochemistry. 2016;39(1):278\u2013293. doi: 10.1159/000445623.", "ArticleIdList": ["10.1159/000445623", "27336168"]}, {"Citation": "El-Baky A. E. A. Quercetin protective action on oxidative stress, sorbitol, insulin risistance and \u03b2-cells function in expermintal diabetic rats. International Journal of Pharmaceutical Studies and Research. 2011;2:11\u201318."}, {"Citation": "Shao Y., Yu Y., Li C., Yu J., Zong R., Pei C. Synergistic effect of quercetin and 6-gingerol treatment in streptozotocin induced type 2 diabetic rats and poloxamer P-407 induced hyperlipidemia. RSC Advances. 2016;6(15):12235\u201312242. doi: 10.1039/C5RA16493A.", "ArticleIdList": ["10.1039/C5RA16493A"]}, {"Citation": "Gaballah H. H., Zakaria S. S., Mwafy S. E., Tahoon N. M., Ebeid A. M. Mechanistic insights into the effects of quercetin and/or GLP-1 analogue liraglutide on high-fat diet/streptozotocin-induced type 2 diabetes in rats. Biomedicine & Pharmacotherapy. 2017;92:331\u2013339. doi: 10.1016/j.biopha.2017.05.086.", "ArticleIdList": ["10.1016/j.biopha.2017.05.086", "28554128"]}, {"Citation": "Chuang C. C., Martinez K., Xie G., et al. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. The American Journal of Clinical Nutrition. 2010;92(6):1511\u20131521. doi: 10.3945/ajcn.2010.29807.", "ArticleIdList": ["10.3945/ajcn.2010.29807", "20943792"]}, {"Citation": "Zhang Q. Y., Pan Y., Wang R., et al. Quercetin inhibits AMPK/TXNIP activation and reduces inflammatory lesions to improve insulin signaling defect in the hypothalamus of high fructose-fed rats. The Journal of Nutritional Biochemistry. 2014;25(4):420\u2013428. doi: 10.1016/j.jnutbio.2013.11.014.", "ArticleIdList": ["10.1016/j.jnutbio.2013.11.014", "24491314"]}, {"Citation": "Dhanya R., Arya A. D., Nisha P., Jayamurthy P. Quercetin, a lead compound against type 2 diabetes ameliorates glucose uptake via AMPK pathway in skeletal muscle cell line. Frontiers in Pharmacology. 2017;8:p. 336. doi: 10.3389/fphar.2017.00336.", "ArticleIdList": ["10.3389/fphar.2017.00336", "PMC5462925", "28642704"]}, {"Citation": "Sandeep M. S., Nandini C. D. Influence of quercetin, naringenin and berberine on glucose transporters and insulin signalling molecules in brain of streptozotocin-induced diabetic rats. Biomedicine & Pharmacotherapy. 2017;94:605\u2013611. doi: 10.1016/j.biopha.2017.07.142.", "ArticleIdList": ["10.1016/j.biopha.2017.07.142", "28783583"]}, {"Citation": "Eid H. M., Nachar A., Thong F., Sweeney G., Haddad P. S. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacognosy Magazine. 2015;11(41):74\u201381. doi: 10.4103/0973-1296.149708.", "ArticleIdList": ["10.4103/0973-1296.149708", "PMC4329636", "25709214"]}, {"Citation": "Yang D. K., Kang H. S. Anti-diabetic effect of cotreatment with quercetin and resveratrol in streptozotocin-induced diabetic rats. Biomolecules & Therapeutics. 2018;26(2):130\u2013138. doi: 10.4062/biomolther.2017.254.", "ArticleIdList": ["10.4062/biomolther.2017.254", "PMC5839491", "29462848"]}, {"Citation": "Peng J., Li Q., Li K., et al. Quercetin improves glucose and lipid metabolism of diabetic rats: involvement of Akt signaling and SIRT1. Journal Diabetes Research. 2017;2017, article 3417306:10. doi: 10.1155/2017/3417306.", "ArticleIdList": ["10.1155/2017/3417306", "PMC5742905", "29379801"]}, {"Citation": "Alam M. M., Meerza D., Naseem I. Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sciences. 2014;109(1):8\u201314. doi: 10.1016/j.lfs.2014.06.005.", "ArticleIdList": ["10.1016/j.lfs.2014.06.005", "24946265"]}, {"Citation": "Eid H. M., Martineau L. C., Saleem A., et al. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Molecular Nutrition & Food Research. 2010;54(7):991\u20131003. doi: 10.1002/mnfr.200900218.", "ArticleIdList": ["10.1002/mnfr.200900218", "20087853"]}, {"Citation": "Xiao N., Mei F., Sun Y., Pan G., Liu B., Liu K. Quercetin, luteolin, and epigallocatechin gallate promote glucose disposal in adipocytes with regulation of AMP-activated kinase and/or sirtuin 1 activity. Planta Medica. 2014;80(12):993\u20131000. doi: 10.1055/s-0034-1382864.", "ArticleIdList": ["10.1055/s-0034-1382864", "25057854"]}, {"Citation": "Vessal M., Hemmati M., Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2003;135(3):357\u2013364. doi: 10.1016/S1532-0456(03)00140-6.", "ArticleIdList": ["10.1016/S1532-0456(03)00140-6", "12927910"]}, {"Citation": "Oboh G., Ademosun A. O., Ayeni P. O., Omojokun O. S., Bello F. Comparative effect of quercetin and rutin on \u03b1-amylase, \u03b1-glucosidase, and some pro-oxidant-induced lipid peroxidation in rat pancreas. Comparative Clinical Pathology. 2014;24:1103\u20131110. doi: 10.1007/s00580-014-2040-5.", "ArticleIdList": ["10.1007/s00580-014-2040-5"]}, {"Citation": "Fontana Pereira D., Cazarolli L. H., Lavado C., et al. Effects of flavonoids on \u03b1-glucosidase activity: potential targets for glucose homeostasis. Nutrition. 2011;27(11-12):1161\u20131167. doi: 10.1016/j.nut.2011.01.008.", "ArticleIdList": ["10.1016/j.nut.2011.01.008", "21684120"]}, {"Citation": "Rifaai R. A., El-Tahawy N. F., Ali S. E. Effect of quercetin on the endocrine pancreas of the experimentally induced diabetes in male albino rats: a histological and immunohistochemical study. Journal of Diabetes & Metabolism. 2012;3:p. 3. doi: 10.4172/2155-6156.1000182.", "ArticleIdList": ["10.4172/2155-6156.1000182"]}, {"Citation": "Eitah H. E., Maklad Y. A., Abdelkader N. F., Gamal El Din A. A., Badawi M. A., Kenawy S. A. Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats. Toxicology and Applied Pharmacology. 2019;365:30\u201340. doi: 10.1016/j.taap.2018.12.011.", "ArticleIdList": ["10.1016/j.taap.2018.12.011", "30576699"]}, {"Citation": "Rivera L., Moron R., Sanchez M., Zarzuelo A., Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 2008;16(9):2081\u20132087. doi: 10.1038/oby.2008.315.", "ArticleIdList": ["10.1038/oby.2008.315", "18551111"]}, {"Citation": "Zahedi M., Ghiasvand R., Feizi A., Asgari G., Darvish L. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. International Journal of Preventive Medicine. 2013;4(7):777\u2013785.", "ArticleIdList": ["PMC3775217", "24049596"]}, {"Citation": "Roslan J., Giribabu N., Karim K., Salleh N. Quercetin ameliorates oxidative stress, inflammation and apoptosis in the heart of streptozotocin-nicotinamide-induced adult male diabetic rats. Biomedicine & Pharmacotherapy. 2017;86:570\u2013582. doi: 10.1016/j.biopha.2016.12.044.", "ArticleIdList": ["10.1016/j.biopha.2016.12.044", "28027533"]}, {"Citation": "Fedosova N. F., Alisievich S. V., Lyadov K. V., Romanova E. P., Rud'ko I. A., Kubatiev A. A. Mechanisms underlying diquertin-mediated regulation of neutrophil function in patients with non-insulin-dependent diabetes mellitus. Bulletin of Experimental Biology and Medicine. 2004;137(2):143\u2013146. doi: 10.1023/B:BEBM.0000028124.90768.50.", "ArticleIdList": ["10.1023/B:BEBM.0000028124.90768.50", "15273759"]}, {"Citation": "Salah O., Bashir M. D. Hepatoprotective role for quercetin in diabetic rats: hypolipidemic and antioxidant effects. The Medical Journal of Cairo University. 2014;82:169\u2013178."}, {"Citation": "Jeong S. M., Kang M. J., Choi H. N., Kim J. H., Kim J. I. Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutrition Research and Practice. 2012;6(3):201\u2013207. doi: 10.4162/nrp.2012.6.3.201.", "ArticleIdList": ["10.4162/nrp.2012.6.3.201", "PMC3395784", "22808343"]}, {"Citation": "Elbe H., Esrefoglu M., Vardi N., Taslidere E., Ozerol E., Tanbek K. Melatonin, quercetin and resveratrol attenuates oxidative hepatocellular injury in streptozotocin-induced diabetic rats. Human & Experimental Toxicology. 2015;34(9):859\u2013868. doi: 10.1177/0960327114559993.", "ArticleIdList": ["10.1177/0960327114559993", "26286521"]}, {"Citation": "Senyigit A., Durmus S., Mirzatas E. B., et al. Effects of quercetin on lipid and protein damage in the liver of streptozotocin-induced experimental diabetic rats. Journal of Medicinal Food. 2019;22(1):52\u201356. doi: 10.1089/jmf.2018.0030.", "ArticleIdList": ["10.1089/jmf.2018.0030", "30285538"]}, {"Citation": "Adewole S. O., Caxton-Martins E. A., Ojewole J. A. O. Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. African Journal of Traditional, Complementary, and Alternative Medicines. 2006;4:64\u201374.", "ArticleIdList": ["PMC2816429", "20162074"]}, {"Citation": "Dokumacioglu E., Iskender H., Sen T. M., et al. The effects of hesperidin and quercetin on serum tumor necrosis factor-alpha and interleukin-6 levels in streptozotocin-induced diabetes model. Pharmacognosy Magazine. 2018;14(54):167\u2013173. doi: 10.4103/pm.pm_41_17.", "ArticleIdList": ["10.4103/pm.pm_41_17", "PMC5909310", "29720826"]}, {"Citation": "Maciel R. M., Costa M. M., Martins D. B., et al. Antioxidant and anti-inflammatory effects of quercetin in functional and morphological alterations in streptozotocin-induced diabetic rats. Research in Veterinary Science. 2013;95(2):389\u2013397. doi: 10.1016/j.rvsc.2013.04.028.", "ArticleIdList": ["10.1016/j.rvsc.2013.04.028", "23706762"]}, {"Citation": "Chis I. C., Muresan A., Oros A., Nagy A. L., Clichici S. Protective effects of quercetin and chronic moderate exercise (training) against oxidative stress in the liver tissue of streptozotocin-induced diabetic rats. Acta Physiologica Hungarica. 2016;103(1):49\u201364. doi: 10.1556/036.103.2016.1.5.", "ArticleIdList": ["10.1556/036.103.2016.1.5", "27030627"]}, {"Citation": "Iskender H., Dokumacioglu E., Sen T. M., Ince I., Kanbay Y., Saral S. The effect of hesperidin and quercetin on oxidative stress, NF-\u03baB and SIRT1 levels in a STZ-induced experimental diabetes model. Biomedicine & Pharmacotherapy. 2017;90:500\u2013508. doi: 10.1016/j.biopha.2017.03.102.", "ArticleIdList": ["10.1016/j.biopha.2017.03.102", "28395272"]}, {"Citation": "Daniel O. O., Adeoye A. O., Ojowu J., Olorunsogo O. O. Inhibition of liver mitochondrial membrane permeability transition pore opening by quercetin and vitamin E in streptozotocin-induced diabetic rats. Biochemical and Biophysical Research Communications. 2018;504(2):460\u2013469. doi: 10.1016/j.bbrc.2018.08.114.", "ArticleIdList": ["10.1016/j.bbrc.2018.08.114", "30195498"]}, {"Citation": "Zhang Y., Dong H., Wang M., Zhang J. Quercetin isolated from Toona sinensis leaves attenuates hyperglycemia and protects hepatocytes in high-carbohydrate/high-fat diet and alloxan induced experimental diabetic mice. Journal Diabetes Research. 2016;2016, article 8492780:10. doi: 10.1155/2016/8492780.", "ArticleIdList": ["10.1155/2016/8492780", "PMC5126429", "27975068"]}, {"Citation": "L\u00f3pez L., Varea O., Navarro S., et al. Benzbromarone, quercetin, and folic acid inhibit amylin aggregation. International Journal of Molecular Sciences. 2016;17(6):p. 964. doi: 10.3390/ijms17060964.", "ArticleIdList": ["10.3390/ijms17060964", "PMC4926496", "27322259"]}, {"Citation": "Kanter M., Aktas C., Erboga M. Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis. Food and Chemical Toxicology. 2012;50(3-4):719\u2013725. doi: 10.1016/j.fct.2011.11.051.", "ArticleIdList": ["10.1016/j.fct.2011.11.051", "22166789"]}, {"Citation": "Lin C. F., Kuo Y. T., Chen T. Y., Chien C. T. Quercetin-rich guava (Psidium guajava) juice in combination with trehalose reduces autophagy, apoptosis and pyroptosis formation in the kidney and pancreas of type II diabetic rats. Molecules. 2016;21(3):p. 334. doi: 10.3390/molecules21030334.", "ArticleIdList": ["10.3390/molecules21030334", "PMC6274302", "26978332"]}, {"Citation": "Suganya N., Mani K. P., Sireesh D., et al. Establishment of pancreatic microenvironment model of ER stress: quercetin attenuates \u03b2-cell apoptosis by invoking nitric oxide-cGMP signaling in endothelial cells. The Journal of Nutritional Biochemistry. 2018;55:142\u2013156. doi: 10.1016/j.jnutbio.2017.12.012.", "ArticleIdList": ["10.1016/j.jnutbio.2017.12.012", "29455095"]}, {"Citation": "Cai X., Bao L., Dai X., Ding Y., Zhang Z., Li Y. Quercetin protects RAW264.7 macrophages from glucosamine-induced apoptosis and lipid accumulation via the endoplasmic reticulum stress pathway. Molecular Medicine Reports. 2015;12(5):7545\u20137553. doi: 10.3892/mmr.2015.4340.", "ArticleIdList": ["10.3892/mmr.2015.4340", "26398703"]}, {"Citation": "Cai X., Bao L., Ding Y., Dai X., Zhang Z., Li Y. Quercetin alleviates cell apoptosis and inflammation via the ER stress pathway in vascular endothelial cells cultured in high concentrations of glucosamine. Molecular Medicine Reports. 2017;15(2):825\u2013832. doi: 10.3892/mmr.2016.6054.", "ArticleIdList": ["10.3892/mmr.2016.6054", "28000870"]}, {"Citation": "Chen S.-Y., Chu C.-C., Lin Y.-C., Duh P.-D. Djulis (Chenopodium formosanum) and its bioactive compounds for management of hyperlipidemia and hyperglycemia in high-fat diet-fed mice. Journal of Food and Nutrition Research. 2019;7(6):452\u2013457. doi: 10.12691/jfnr-7-6-7.", "ArticleIdList": ["10.12691/jfnr-7-6-7"]}, {"Citation": "Sikder K., Das N., Kesh S. B., Dey S. Quercetin and \u03b2-sitosterol prevent high fat diet induced dyslipidemia and hepatotoxicity in Swiss albino mice. Indian Journal of Experimental Biology. 2014;52(1):60\u201366.", "ArticleIdList": ["24617016"]}, {"Citation": "Mariee A. D., Abd-Allah G. M., El-Beshbishy H. A. Protective effect of dietary flavonoid quercetin against lipemic-oxidative hepatic injury in hypercholesterolemic rats. Pharmaceutical Biology. 2012;50(8):1019\u20131025. doi: 10.3109/13880209.2012.655424.", "ArticleIdList": ["10.3109/13880209.2012.655424", "22775419"]}, {"Citation": "Ju\u017awiak S., W\u00f3jcicki J., Mokrzycki K., et al. Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits. Pharmacological Reports. 2005;57(5):604\u2013609.", "ArticleIdList": ["16227643"]}, {"Citation": "Braun J. B. S., Ruchel J. B., Adefegha S. A., et al. Neuroprotective effects of pretreatment with quercetin as assessed by acetylcholinesterase assay and behavioral testing in poloxamer-407 induced hyperlipidemic rats. Biomedicine & Pharmacotherapy. 2017;88:1054\u20131063. doi: 10.1016/j.biopha.2017.01.134.", "ArticleIdList": ["10.1016/j.biopha.2017.01.134", "28192878"]}, {"Citation": "Ulasova E., Perez J., Hill B. G., et al. Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouse. Redox Biology. 2013;1(1):381\u2013386. doi: 10.1016/j.redox.2013.07.001.", "ArticleIdList": ["10.1016/j.redox.2013.07.001", "PMC3757709", "24024175"]}, {"Citation": "Hu Q. H., Zhang X., Pan Y., Li Y. C., Kong L. D. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats. Biochemical Pharmacology. 2012;84(1):113\u2013125. doi: 10.1016/j.bcp.2012.03.005.", "ArticleIdList": ["10.1016/j.bcp.2012.03.005", "22426011"]}, {"Citation": "Nekohashi M., Ogawa M., Ogihara T., et al. Luteolin and quercetin affect the cholesterol absorption mediated by epithelial cholesterol transporter Niemann-Pick c1-like 1 in caco-2 cells and rats. PLoS One. 2014;9(5, article e97901) doi: 10.1371/journal.pone.0097901.", "ArticleIdList": ["10.1371/journal.pone.0097901", "PMC4032257", "24859282"]}, {"Citation": "Jung C. H., Cho I., Ahn J., Jeon T. I., Ha T. Y. Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytotherapy Research. 2013;27(1):139\u2013143. doi: 10.1002/ptr.4687.", "ArticleIdList": ["10.1002/ptr.4687", "22447684"]}, {"Citation": "Kobori M., Masumoto S., Akimoto Y., Oike H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Molecular Nutrition & Food Research. 2011;55(4):530\u2013540. doi: 10.1002/mnfr.201000392.", "ArticleIdList": ["10.1002/mnfr.201000392", "21462320"]}, {"Citation": "Lee S. M., Moon J., Cho Y., Chung J. H., Shin M. J. Quercetin up-regulates expressions of peroxisome proliferator-activated receptor \u03b3, liver X receptor \u03b1 , and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage cell line. Nutrition Research. 2013;33(2):136\u2013143. doi: 10.1016/j.nutres.2012.11.010.", "ArticleIdList": ["10.1016/j.nutres.2012.11.010", "23399664"]}, {"Citation": "Ragab S. M., Abd Elghaffar S., el-Metwally T. H., Badr G., Mahmoud M. H., Omar H. M. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds. Lipids in Health and Disease. 2015;14(1) doi: 10.1186/s12944-015-0087-1.", "ArticleIdList": ["10.1186/s12944-015-0087-1", "PMC4520282", "26228038"]}, {"Citation": "Krishna Mohan S., Jainu M. Effect of pioglitazone, quercetin, and hydroxy citric acid on the lipid profile and lipoproteins in experimentally induced non-alcoholic steatohepatitis (NASH) Indian Journal of Pharmaceutical Education and Research. 2014;48(1):32\u201338. doi: 10.5530/ijper.48.1.6.", "ArticleIdList": ["10.5530/ijper.48.1.6"]}, {"Citation": "Zhu X., Xiong T., Liu P., et al. Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a/XBP1s pathway. Food and Chemical Toxicology. 2018;114:52\u201360. doi: 10.1016/j.fct.2018.02.019.", "ArticleIdList": ["10.1016/j.fct.2018.02.019", "29438776"]}, {"Citation": "Pisonero-Vaquero S., Mart\u00ednez-Ferreras \u00c1., Garc\u00eda-Mediavilla M. V., et al. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease. Molecular Nutrition & Food Research. 2015;59(5):879\u2013893. doi: 10.1002/mnfr.201400913.", "ArticleIdList": ["10.1002/mnfr.201400913", "25712622"]}, {"Citation": "Li X., Wang R., Zhou N., et al. Quercetin improves insulin resistance and hepatic lipid accumulation in vitro in a NAFLD cell model. Biomedical Reports. 2013;1(1):71\u201376. doi: 10.3892/br.2012.27.", "ArticleIdList": ["10.3892/br.2012.27", "PMC3956827", "24648896"]}, {"Citation": "Liu P., Lin H., Xu Y., et al. Frataxin-mediated PINK1-Parkin-dependent mitophagy in hepatic steatosis: the protective effects of quercetin. Molecular Nutrition & Food Research. 2018;62(16, article e1800164) doi: 10.1002/mnfr.201800164.", "ArticleIdList": ["10.1002/mnfr.201800164", "29935106"]}, {"Citation": "Liu L., Gao C., Yao P., Gong Z. Quercetin alleviates high-fat diet-induced oxidized low-density lipoprotein accumulation in the liver: implication for autophagy regulation. BioMed Research International. 2015;2015:9. doi: 10.1155/2015/607531.607531", "ArticleIdList": ["10.1155/2015/607531", "PMC4678061", "26697490"]}, {"Citation": "Yang H., Yang T., Heng C., et al. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice. Phytotherapy Research. 2019;33(12):3140\u20133152. doi: 10.1002/ptr.6486.", "ArticleIdList": ["10.1002/ptr.6486", "31452288"]}, {"Citation": "Mohan S. K., Jainu M. Effect of pioglitazone, quercetin and hydroxy citric acid on inflammatory markers in experimentally induced non alcoholic steatohepatitis (NASH) Indian Journal of Pharmaceutical Education and Research. 2015;49(2):152\u2013157. doi: 10.5530/ijper.49.2.12.", "ArticleIdList": ["10.5530/ijper.49.2.12"]}, {"Citation": "Ying H. Z., Liu Y. H., Yu B., Wang Z. Y., Zang J. N., Yu C. H. Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. Food and Chemical Toxicology. 2013;52:53\u201360. doi: 10.1016/j.fct.2012.10.030.", "ArticleIdList": ["10.1016/j.fct.2012.10.030", "23123425"]}, {"Citation": "Marcolin E., San-Miguel B., Vallejo D., et al. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. The Journal of Nutrition. 2012;142(10):1821\u20131828. doi: 10.3945/jn.112.165274.", "ArticleIdList": ["10.3945/jn.112.165274", "22915297"]}, {"Citation": "Surapaneni K. M., Jainu M. Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis. Journal of Physiology and Pharmacology. 2014;65(1):67\u201374.", "ArticleIdList": ["24622831"]}, {"Citation": "Surapaneni K. M., Priya V. V., Mallika J. Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH) European Review for Medical and Pharmacological Sciences. 2014;18(18):2736\u20132741.", "ArticleIdList": ["25317811"]}, {"Citation": "Li Q., Zhao C., Zhang Y., et al. 1H-NMR-based metabolomics coupled with molecular docking reveal the anti-diabetic effects and potential active components of berberis vernae on type 2 diabetic rats. Frontiers in Pharmacology. 2020;11:p. 932. doi: 10.3389/fphar.2020.00932.", "ArticleIdList": ["10.3389/fphar.2020.00932", "PMC7317004", "32636751"]}, {"Citation": "Xu Y., Han J., Dong J., et al. Metabolomics characterizes the effects and mechanisms of quercetin in nonalcoholic fatty liver disease development. International Journal of Molecular Sciences. 2019;20(5):p. 1220. doi: 10.3390/ijms20051220.", "ArticleIdList": ["10.3390/ijms20051220", "PMC6429195", "30862046"]}, {"Citation": "Kolodziejczyk A. A., Zheng D., Shibolet O., Elinav E. The role of the microbiome in NAFLD and NASH. EMBO Molecular Medicine. 2019;11(2, article e9302) doi: 10.15252/emmm.201809302.", "ArticleIdList": ["10.15252/emmm.201809302", "PMC6365925", "30591521"]}, {"Citation": "Leung C., Rivera L., Furness J. B., Angus P. W. The role of the gut microbiota in NAFLD. Nature Reviews. Gastroenterology & Hepatology. 2016;13(7):412\u2013425. doi: 10.1038/nrgastro.2016.85.", "ArticleIdList": ["10.1038/nrgastro.2016.85", "27273168"]}, {"Citation": "Chu H., Duan Y., Yang L., Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019;68(2):359\u2013370. doi: 10.1136/gutjnl-2018-316307.", "ArticleIdList": ["10.1136/gutjnl-2018-316307", "30171065"]}, {"Citation": "Porras D., Nistal E., Mart\u00ednez-Fl\u00f3rez S., et al. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology & Medicine. 2017;102:188\u2013202. doi: 10.1016/j.freeradbiomed.2016.11.037.", "ArticleIdList": ["10.1016/j.freeradbiomed.2016.11.037", "27890642"]}, {"Citation": "Porras D., Nistal E., Mart\u00ednez-Fl\u00f3rez S., et al. Functional interactions between gut microbiota transplantation, quercetin, and high-fat diet determine non-alcoholic fatty liver disease development in Germ\u2010Free mice. Molecular Nutrition & Food Research. 2019;63(8, article e1800930) doi: 10.1002/mnfr.201800930.", "ArticleIdList": ["10.1002/mnfr.201800930", "30680920"]}, {"Citation": "Petrov P. D., Garc\u00eda-Mediavilla M. V., Guzm\u00e1n C., et al. A network involving gut microbiota, circulating bile acids, and hepatic metabolism genes that protects against non-alcoholic fatty liver disease. Molecular Nutrition & Food Research. 2019;63(20, article e1900487) doi: 10.1002/mnfr.201900487.", "ArticleIdList": ["10.1002/mnfr.201900487", "31322321"]}, {"Citation": "Knekt P., Kumpulainen J., J\u00e4rvinen R., et al. Flavonoid intake and risk of chronic diseases. The American Journal of Clinical Nutrition. 2002;76(3):560\u2013568. doi: 10.1093/ajcn/76.3.560.", "ArticleIdList": ["10.1093/ajcn/76.3.560", "12198000"]}, {"Citation": "van den Eynde M. D. G., Geleijnse J. M., Scheijen J., et al. Quercetin, but not epicatechin, decreases plasma concentrations of methylglyoxal in adults in a randomized, double-blind, placebo-controlled, crossover trial with pure flavonoids. The Journal of Nutrition. 2018;148(12):1911\u20131916. doi: 10.1093/jn/nxy236.", "ArticleIdList": ["10.1093/jn/nxy236", "30398646"]}, {"Citation": "Hussain S. A., Ahmed Z. A., Mahwi T. O., Aziz T. A. Quercetin dampens postprandial hyperglycemia in type 2 diabetic patients challenged with carbohydrates load. International Journal of Diabetes Research. 2012;1(3):32\u201335. doi: 10.5923/j.diabetes.20120103.01.", "ArticleIdList": ["10.5923/j.diabetes.20120103.01"]}, {"Citation": "Mazloom Z., Abdollahzadeh S. M., Dabbaghmanesh M.-H., Rezaianzadeh A. The effect of quercetin supplementation on oxidative stress, glycemic control, lipid profile and insulin resistance in type 2 diabetes: a randomized clinical trial. Journal of Health Sciences & Surveillance System. 2014;2:8\u201314."}, {"Citation": "Ostadmohammadi V., Milajerdi A., Ayati E., Kolahdooz F., Asemi Z. Effects of quercetin supplementation on glycemic control among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research. 2019;33(5):1330\u20131340. doi: 10.1002/ptr.6334.", "ArticleIdList": ["10.1002/ptr.6334", "30848564"]}, {"Citation": "Lu T. M., Chiu H. F., Shen Y. C., Chung C. C., Venkatakrishnan K., Wang C. K. Hypocholesterolemic efficacy of quercetin rich onion juice in healthy mild hypercholesterolemic adults: a pilot study. Plant Foods for Human Nutrition. 2015;70(4):395\u2013400. doi: 10.1007/s11130-015-0507-4.", "ArticleIdList": ["10.1007/s11130-015-0507-4", "26385226"]}, {"Citation": "Pasdar Y., Oubari F., Zarif M. N., Abbasi M., Pourmahmoudi A., Hosseinikia M. Effects of quercetin supplementation on hematological parameters in non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Clinical Nutrition Research. 2020;9(1):11\u201319. doi: 10.7762/cnr.2020.9.1.11.", "ArticleIdList": ["10.7762/cnr.2020.9.1.11", "PMC7015726", "32095444"]}, {"Citation": "Salehi B., Machin L., Monzote L., et al. Therapeutic potential of quercetin: new insights and perspectives for human health. ACS Omega. 2020;5(20):11849\u201311872. doi: 10.1021/acsomega.0c01818.", "ArticleIdList": ["10.1021/acsomega.0c01818", "PMC7254783", "32478277"]}, {"Citation": "Singh J., Mittal P., Vasant Bonde G., Ajmal G., Mishra B. Design, optimization, characterization and in-vivo evaluation of quercetin enveloped Soluplus\u00ae/P407 micelles in diabetes treatment. Artificial Cells, Nanomedicine, and Biotechnology. 2018;46(sup3):S546\u2013S555. doi: 10.1080/21691401.2018.1501379.", "ArticleIdList": ["10.1080/21691401.2018.1501379", "30322273"]}, {"Citation": "Riva A., Corti A., Belcaro G., et al. Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. Minerva Cardioangiologica. 2019;67(1):79\u201383. doi: 10.23736/S0026-4725.18.04795-3.", "ArticleIdList": ["10.23736/S0026-4725.18.04795-3", "30226032"]}, {"Citation": "Singh A. P., Singh R., Verma S. S., et al. Health benefits of resveratrol: evidence from clinical studies. Medicinal Research Reviews. 2019;39(5):1851\u20131891. doi: 10.1002/med.21565.", "ArticleIdList": ["10.1002/med.21565", "30741437"]}, {"Citation": "Fan Y., Pedersen O. Gut microbiota in human metabolic health and disease. Nature Reviews. Microbiology. 2021;19(1):55\u201371. doi: 10.1038/s41579-020-0433-9.", "ArticleIdList": ["10.1038/s41579-020-0433-9", "32887946"]}, {"Citation": "Xu J., Chen H. B., Li S. L. Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota. Medicinal Research Reviews. 2017;37(5):1140\u20131185. doi: 10.1002/med.21431.", "ArticleIdList": ["10.1002/med.21431", "28052344"]}, {"Citation": "Xie J., Song W., Liang X., et al. Protective effect of quercetin on streptozotocin-induced diabetic peripheral neuropathy rats through modulating gut microbiota and reactive oxygen species level. Biomedicine & Pharmacotherapy. 2020;127:p. 110147. doi: 10.1016/j.biopha.2020.110147.", "ArticleIdList": ["10.1016/j.biopha.2020.110147", "32559841"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "19"}, {"Year": "2021", "Month": "1", "Day": "17"}, {"Year": "2021", "Month": "6", "Day": "8"}, {"Year": "2021", "Month": "7", "Day": "14", "Hour": "7", "Minute": "4"}, {"Year": "2021", "Month": "7", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["34257817", "PMC8249127", "10.1155/2021/6678662"]}}], "PubmedBookArticle": []}